BioLeaders

Chief Executive Officer, Oxford Medical Products (April 2023) Oxford Medical Products (OMP) is a clinical staged, VC backed, company providing a non-surgical weight loss product that will redefine the obesity treatment market. Excessive weight affects almost 2 billion people WW, costing the US health system $148bn annually. Our proprietary hydrogel pill is taken orally at home and works like a gastric balloon, without the expense or need for hospital visits. The pills fill 50% of the stomach volume, and stay in the stomach for several weeks, reducing hunger, leading to weight loss. The hydrogel is passed naturally with redosing [...]

Chief Executive Officer, Amphista Therapeutics (March 2023) Nicki has over 25 years’ experience in pharmaceutical and biotechnology R&D in a variety of senior scientific and leadership roles. She was previously VP and Global Head of External Drug Discovery at F. Hoffmann-La Roche Ltd and prior to that, Senior Director, Business Development for GSK’s Centre of Excellence for External Drug Discovery (CEEDD). Nicki’s Biotech experience includes her role as Chair of the Board for Nanna Therapeutics Ltd, founding CEO of VirionHealth and Head of Drug Discovery at Syntaxin Ltd. She holds a PhD in Cell Biology from University College London. [...]

David Reynolds BioLeader Interview - David Reynolds, Chief Executive Officer, LoQus23 Therapeutics, Non-Executive Director, AstronauTx (March 2023) David is a highly experienced pharmaceutical research and development leader having worked for nearly 20 years at Merck Sharp & Dohme, Lundbeck and latterly Pfizer, where he was the Cambridge Neuroscience & Pain Research Site Head. He has held a variety of R&D leadership roles with responsibilities ranging from exploratory biology, through drug discovery, early clinical development and in-licensing in multiple disease areas, with a focus on neuroscience and pain. Before joining the Dementia Discovery Fund he spent three years as the [...]

Matt Regan BioLeader Interview - Matt Regan, Chief Executive Officer, Micreos Pharmaceuticals (February 2023) Senior, international, Healthcare leader with 30-years of research-based Biopharmaceutical & Medical device experience with Global leaders such as Abbott, AbbVie and Novo Nordisk. Currently CEO with the Clinical stage Biotech Company Micreos Pharma. Broad, diverse experience having held leadership roles in Manufacturing, Engineering, Supply Chain management, HR management, Research & Development as well as very significant commercial leadership roles at the Country and Regional level. Authentic, values-driven leader with the ability to inspire large organizations to transform, to build new capabilities, and to raise the [...]

David Van Sickle BioLeader Interview - David Van Sickle, Healthtech Entrepreneur, Executive and Board Director (December 2022) I have more than 15 years experience developing and commercializing digital health technologies. From 2010, I was the co-founder and CEO of Propeller Health, a digital health + therapeutics company dedicated to improving the management of asthma and COPD. At Propeller, we pioneered the application of digital technology to chronic disease management and pharmaceutical therapy. During the company's history, we partnered with health plans, provider systems, PBMs, retail pharmacies, and pharmaceutical manufacturers to bring clinically-proven digital solutions to clinicians and people with [...]

Hakim Yadi BioLeader Interview - Hakim Yadi, Chief Executive Officer & Co-Founder, Closed Loop Medicine (September 2022) Hakim is a Co-Founder and Chief Executive Officer of Closed Loop Medicine (CLM). CLM is a healthcare technology company developing drug + digital combination products, transforming drug effectiveness through optimisation by providing every drug its real time digital companion. Hakim joined Closed Loop Medicine from the Northern Health Science Alliance Ltd, the pan-Northern health partnership which brought together for the first time 20 research-based NHS hospitals, the North’s Academic Health Science Networks and Universities to collaborate on improving health outcomes across the [...]

Jorge Quiroz BioLeader Interview - Jorge Quiroz, Executive Vice President, Chief Medical Officer, NMD Pharma, Boston USA (September 2022) Dr. Quiroz brings twenty years of drug development experience in academic, pharmaceutical and biotechnology industries. He has been responsible for the scientific, clinical, and regulatory strategies across all phases of drug development, globally, including IND filings for rare disorders, and proof of concept and registrational studies for NDA and sNDA. He currently serves as a member of the Board of Directors of Perception Neurosciences and prior to NMD Pharma, Dr. Quiroz served as Chief Medical Officer of venture backed and [...]

Mandeep Dhillon BioLeader Interview - Mandeep Dhillon, KQ Labs Lead - Translation at The Francis Crick Institute (August 2022) Mandeep joined the Crick in 2022 to lead KQ Labs, an accelerator that is focused on supporting early-stage data-driven health start-ups. Prior to KQ Labs, Mandeep was a Partner and Head of Digital Health at BioScience Managers, a global life science venture capital firm. Before stepping into venture capital, Mandeep spent nearly a decade in Management Consulting. In his last role as Principal at Arthur D. Little, he led the Strategy Phase 0 team within the Digital Problem Solving Practice. [...]

Anders Tuv BioLeader Interview - Anders Tuv, Chief Investment Officer at Radforsk, Norway (May 2022) Anders is Chief Investment Officer of the life science investment company Radforsk, which is focused on immunotherapies and precision medicines. He is an experienced investment and business development professional in the life science industry. His roles and responsibilities cover management positions, strategy and business development, research collaborations, licensing deals, M&A and IPOs. Anders also holds several chairman and non-executive director positions. Key milestones in your career journey to date? My time as managing consultant at Ernst & Young Advisory, focused on the healthcare industry, [...]

Agnete Fredriksen BioLeader Interview - Agnete Fredriksen, Co-Founder, Chief Innovation & Strategy Officer at Nykode Therapeutics AS (April 2022) Agnete is a co-founder of Nykode Therapeutics and served as Chief Scientific Officer from 2007-2021, leading the organisation’s scientific strategy. Her previous employers include Affitech AS and Medinnova AS. She is the author of numerous scientific papers in the field of immunology, immunotherapy and vaccines, and has been awarded several patents in the field of immunotherapy. Agnete holds an MSc and a Ph.D. from the Institute of Immunology, Rikshospitalet Medical Center in Oslo, where she designed and developed the first [...]